476 related articles for article (PubMed ID: 16776650)
1. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
[TBL] [Abstract][Full Text] [Related]
2. Seven Dictyostelium discoideum phosphodiesterases degrade three pools of cAMP and cGMP.
Bader S; Kortholt A; Van Haastert PJ
Biochem J; 2007 Feb; 402(1):153-61. PubMed ID: 17040207
[TBL] [Abstract][Full Text] [Related]
3. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
4. TcPDE4, a novel membrane-associated cAMP-specific phosphodiesterase from Trypanosoma cruzi.
Alonso GD; Schoijet AC; Torres HN; Flawiá MM
Mol Biochem Parasitol; 2006 Jan; 145(1):40-9. PubMed ID: 16225937
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.
Rascón A; Soderling SH; Schaefer JB; Beavo JA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4714-9. PubMed ID: 11930017
[TBL] [Abstract][Full Text] [Related]
6. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Matthiesen K; Nielsen J
Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
[TBL] [Abstract][Full Text] [Related]
7. TcrPDEA1, a cAMP-specific phosphodiesterase with atypical pharmacological properties from Trypanosoma cruzi.
Alonso GD; Schoijet AC; Torres HN; Flawiá MM
Mol Biochem Parasitol; 2007 Mar; 152(1):72-9. PubMed ID: 17222469
[TBL] [Abstract][Full Text] [Related]
8. Trypanosome cyclic nucleotide phosphodiesterase 2B binds cAMP through its GAF-A domain.
Laxman S; Rascón A; Beavo JA
J Biol Chem; 2005 Feb; 280(5):3771-9. PubMed ID: 15563461
[TBL] [Abstract][Full Text] [Related]
9. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.
Martinez SE; Wu AY; Glavas NA; Tang XB; Turley S; Hol WG; Beavo JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13260-5. PubMed ID: 12271124
[TBL] [Abstract][Full Text] [Related]
10. Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site-directed mutagenesis and molecular modeling based on crystalline PDE4B.
Zhang W; Ke H; Tretiakova AP; Jameson B; Colman RW
Protein Sci; 2001 Aug; 10(8):1481-9. PubMed ID: 11468344
[TBL] [Abstract][Full Text] [Related]
11. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
Kunz S; Oberholzer M; Seebeck T
FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
Soderling SH; Bayuga SJ; Beavo JA
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
14. Regulation of photoreceptor phosphodiesterase catalysis by its non-catalytic cGMP-binding sites.
D'Amours MR; Cote RH
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):863-9. PubMed ID: 10359674
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase.
Huang D; Hinds TR; Martinez SE; Doneanu C; Beavo JA
J Biol Chem; 2004 Nov; 279(46):48143-51. PubMed ID: 15331594
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A.
Wu AY; Tang XB; Martinez SE; Ikeda K; Beavo JA
J Biol Chem; 2004 Sep; 279(36):37928-38. PubMed ID: 15210692
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
[TBL] [Abstract][Full Text] [Related]
18. Identification, characterization and subcellular localization of TcPDE1, a novel cAMP-specific phosphodiesterase from Trypanosoma cruzi.
D'Angelo MA; Sanguineti S; Reece JM; Birnbaumer L; Torres HN; Flawiá MM
Biochem J; 2004 Feb; 378(Pt 1):63-72. PubMed ID: 14556647
[TBL] [Abstract][Full Text] [Related]
19. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
20. Homology Modeling and Molecular Dynamics Simulations of Trypanosoma cruzi Phosphodiesterase b1.
Llanos MA; Alberca LN; Larrea SCV; Schoijet AC; Alonso GD; Bellera CL; Gavenet L; Talevi A
Chem Biodivers; 2022 Jan; 19(1):e202100712. PubMed ID: 34813143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
